Qifu Xu

Discovery of Novel Pyrrolo[2,3-<i>d</i>]pyrimidine-based Derivatives as Potent JAK/HDAC Dual Inhibitors for the Treatment of Refractory Solid Tumors

Xuewu Liang, Shuai Tang, Xuyi Liu et al. · Journal of Medicinal Chemistry · 2021 · 67 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Development of selective HDAC6 inhibitors with in vitro and in vivo anti-multiple myeloma activity

Shunda Li, Chunlong Zhao, Guozhen Zhang et al. · Bioorganic Chemistry · 2021 · 24 citations

Medicine, Medicinal Chemistry, Pharmacology +9

Discovery of a Novel Hybrid of Vorinostat and Riluzole as a Potent Antitumor Agent

Qifu Xu, Chunxi Liu, Jie Zang et al. · Frontiers in Cell and Developmental Biology · 2020 · 18 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Design, Synthesis, and Biological Evaluation of APN and AKT Dual-Target Inhibitors

Qian Liu, Hang Dong, Wei Zhao et al. · ACS Medicinal Chemistry Letters · 2021 · 12 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Synthesis and biological study of class I selective HDAC inhibitors with NO releasing activity

Qin'ge Ding, Chunxi Liu, Chunlong Zhao et al. · Bioorganic Chemistry · 2020 · 10 citations

Pharmacy, Medicinal Chemistry, Pharmacology +11